These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 7683116)
1. Distribution and metabolism of NG-nitro-L-arginine and NG-nitro-L-arginine methylester in canine blood in vitro. Krejcy K; Schwarzacher S; Raberger G Naunyn Schmiedebergs Arch Pharmacol; 1993 Mar; 347(3):342-5. PubMed ID: 7683116 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of nitric oxide synthesis by NG-nitro-L-arginine methyl ester (L-NAME): requirement for bioactivation to the free acid, NG-nitro-L-arginine. Pfeiffer S; Leopold E; Schmidt K; Brunner F; Mayer B Br J Pharmacol; 1996 Jul; 118(6):1433-40. PubMed ID: 8832069 [TBL] [Abstract][Full Text] [Related]
3. Distribution and metabolism of N(G)-nitro-L-arginine methyl ester in patients with septic shock. Avontuur JA; Buijk SL; Bruining HA Eur J Clin Pharmacol; 1998 Oct; 54(8):627-31. PubMed ID: 9860150 [TBL] [Abstract][Full Text] [Related]
4. Determination of NG-nitro-L-arginine and NG-nitro-L-arginine methyl ester in plasma by high-performance liquid chromatography. Whiting MJ; Rutten AJ; Williams P; Bersten AD J Chromatogr B Biomed Appl; 1994 Oct; 660(1):170-5. PubMed ID: 7858710 [TBL] [Abstract][Full Text] [Related]
5. Interactions of nitric oxide synthase inhibitors and dexamethasone with alpha-adrenoceptor-mediated responses in rat aorta. Adeagbo AS; Triggle CR Br J Pharmacol; 1993 Jun; 109(2):495-501. PubMed ID: 7689395 [TBL] [Abstract][Full Text] [Related]
6. Effects of NG-substituted arginines on coronary vascular function after endotoxin. Winn MJ; Vallet B; Asante NK; Curtis SE; Cain SM J Appl Physiol (1985); 1993 Jul; 75(1):424-31. PubMed ID: 7690746 [TBL] [Abstract][Full Text] [Related]
7. In vivo metabolites of N omega-nitro-L-arginine methyl ester: methanol and N omega-nitro-L-arginine. Brouillet E; Roeda D; Valette H; Fuseau C; Guyot MC; Crouzel C Eur J Pharmacol; 1995 Dec; 293(4):487-90. PubMed ID: 8748703 [TBL] [Abstract][Full Text] [Related]
8. Assessment of renal dopaminergic system activity in the nitric oxide-deprived hypertensive rat model. Soares-da-Silva P; Pestana M; Vieira-Coelho MA; Fernandes MH; Albino-Teixeira A Br J Pharmacol; 1995 Apr; 114(7):1403-13. PubMed ID: 7541690 [TBL] [Abstract][Full Text] [Related]
9. NG-nitro L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists. Buxton IL; Cheek DJ; Eckman D; Westfall DP; Sanders KM; Keef KD Circ Res; 1993 Feb; 72(2):387-95. PubMed ID: 7678206 [TBL] [Abstract][Full Text] [Related]
10. Comparison of effects of chronic and acute administration of NG-nitro-L-arginine methyl ester to the rat on inhibition of nitric oxide-mediated responses. Bryant CE; Allcock GH; Warner TD Br J Pharmacol; 1995 Apr; 114(8):1673-9. PubMed ID: 7541283 [TBL] [Abstract][Full Text] [Related]
11. Exercise-induced hyperaemia and leg oxygen uptake are not altered during effective inhibition of nitric oxide synthase with N(G)-nitro-L-arginine methyl ester in humans. Frandsenn U; Bangsbo J; Sander M; Höffner L; Betak A; Saltin B; Hellsten Y J Physiol; 2001 Feb; 531(Pt 1):257-64. PubMed ID: 11179408 [TBL] [Abstract][Full Text] [Related]
12. Anti-nociceptive activity of nitric oxide synthase inhibitors in the mouse: dissociation between the effect of L-NAME and L-NMMA. Babbedge RC; Hart SL; Moore PK J Pharm Pharmacol; 1993 Jan; 45(1):77-9. PubMed ID: 7679442 [TBL] [Abstract][Full Text] [Related]
13. [Study on roles of L-arginine to nitric oxide pathway for the cardiovascular control: assessment with a new model of hypertension produced by the chronic administration of nitric oxide synthase inhibitor]. Shudo H Hokkaido Igaku Zasshi; 1994 Jul; 69(4):967-77. PubMed ID: 7525439 [TBL] [Abstract][Full Text] [Related]
14. Influence of nitric oxide synthase inhibition, nitric oxide and hydroperoxide on insulin release induced by various secretagogues. Panagiotidis G; Akesson B; Rydell EL; Lundquist I Br J Pharmacol; 1995 Jan; 114(2):289-96. PubMed ID: 7533613 [TBL] [Abstract][Full Text] [Related]
15. Failure of L-nitroarginine to inhibit the activity of aortic inducible nitric oxide synthase. Darblade B; Batkai S; Caussé E; Gourdy P; Fouque MJ; Rami J; Arnal JF J Vasc Res; 2001; 38(3):266-75. PubMed ID: 11399899 [TBL] [Abstract][Full Text] [Related]
16. Metabolism of methylarginines by human vasculature; implications for the regulation of nitric oxide synthesis. MacAllister RJ; Fickling SA; Whitley GS; Vallance P Br J Pharmacol; 1994 May; 112(1):43-8. PubMed ID: 7518309 [TBL] [Abstract][Full Text] [Related]
17. Time-dependent enhancement or inhibition of endotoxin-induced vascular injury in rat intestine by nitric oxide synthase inhibitors. Laszlo F; Whittle BJ; Moncada S Br J Pharmacol; 1994 Apr; 111(4):1309-15. PubMed ID: 7518298 [TBL] [Abstract][Full Text] [Related]
18. Delayed gastric emptying induced by inhibitors of nitric oxide synthase in rats. Plourde V; Quintero E; Suto G; Coimbra C; Taché Y Eur J Pharmacol; 1994 Apr; 256(2):125-9. PubMed ID: 7519557 [TBL] [Abstract][Full Text] [Related]
19. Potent inhibition of human neuronal nitric oxide synthase by N(G)-nitro-L-arginine methyl ester results from contaminating N(G)-nitro-L-arginine. Furfine ES; Carbine K; Bunker S; Tanoury G; Harmon M; Laubach V; Sherman P Life Sci; 1997; 60(20):1803-9. PubMed ID: 9150420 [TBL] [Abstract][Full Text] [Related]
20. The nitric oxide synthase inhibitor NW-nitro-L-arginine methylester attenuates brain catalase activity in vitro. Rotzinger S; Aragon CM; Rogan F; Amir S; Amit Z Life Sci; 1995 Mar; 56(16):1321-4. PubMed ID: 8614253 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]